from 1978 to 1982 , selected `` '' poor-risk '' '' advanced-stage patients received nitrogen mustard , vincristine , procarbazine , prednisone plus adriamycin ( doxorubicin ; adria laboratories , columbus , oh ) , bleomycin , vinblastine , and dacarbazine ( mopp-abvd ) induction chemotherapy , while the remaining patients were randomized between mvvpp and mopp .
C0005740
, bleomyc
C0280554
( mopp-ab